Early intervention in bipolar disorder, part I: Clinical and imaging findings

Early Intervention in Psychiatry

Volumn 2, Issue 3, 2008, Pages 122-135

  Salvadore, Giacomo ^a   Drevets, Wayne C ^a   Henter, Ioline D ^a   Zarate, Carlos A ^a   Manji, Husseini K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Bipolar disorder; Early intervention; First episode; High risk; Imaging

Indexed keywords

ANTIDEPRESSANT AGENT; CALBINDIN; GLUTAMIC ACID; LITHIUM SALT; N ACETYLASPARTIC ACID; PARVALBUMIN;

BIPOLAR DISORDER; BORDERLINE STATE; BRAIN RADIOGRAPHY; COGNITIVE DEFECT; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; EARLY INTERVENTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR DEPRESSION; MANIA; MOOD DISORDER; NEUROIMAGING; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPATHY; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; STRESS; TWINS; WHITE MATTER;

ADOLESCENT; ADULT; BIPOLAR DISORDER; BRAIN; EARLY DIAGNOSIS; HUMANS; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65249154321     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2008.00071.x     Document Type: Review

References (132)

1. Cameron DE. Early schizophrenia. Am J Psychiatry 1938; 95: 567-78.
2. McGlashan TH, Zipursky R, Perkins D et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790-9.
3. McGorry P, Yung A, Phillips L et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921-8.
4. Berger G, Wood S, McGorry P. Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacol Bull 2003; 37: 79-101.
5. McGorry P. Early intervention in psychotic disorders: Beyond debate to solving problems. Br J Psychiatry 2005; 48: S108-10.
6. Remmington G, Shammi C. The use of phamacotherapy in the prodrome of schizophrenia. CNS Spectr 2004; 9: 579-86.
7. Scott J, Meyer TD. Editorial: Prospects for early intervention in bipolar disorders. Early Int Psychiatry 2007; 1: 111-3.
8. Warner R. Problems with early and very early intervention in psychosis. Br J Psychiatry 2005; 48: S104-7.
9. Christodoulou GN, Christodoulou NG. Editorial: Early intervention in psychiatry. Early Int Psychiatry 2007; 1: 7-8.
10. Judd LL, Akiskal HS, Schettler PJ et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II patients. Arch Gen Psychiatry 2003; 60: 261-9.
11. Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-7.
12. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. New York: Oxford University Press, 2007.
13. Paykel ES, Abbott R, Morriss R, Hayhurst H, Scott J. Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder. Br J Psychiatry 2006; 189: 118-23.
14. Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E, Board EA. Functional impairment in patients with mania: Baseline results of the EMBLEM study. Bipolar Disord 2007; 9: 45-52.
15. Thompson WK, Kupfer DJ, Fagiolini A, Scott J, Frank E. Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: Analysis of acute-phase data from a randomized controlled trial. J Clin Psychiatry 2006; 67: 783-8.
16. McElroy SL. Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry 2004; 65 (Suppl. 15): S35-44.
17. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000; 48: 813-29.
18. Merikangas KR, Akiskal HS, Angst J et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64: 543-52.
19. Baldessarini RJ, Tondo L, Baethge C, Lepri B, Bratti IM. Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. Bipolar Disord 2007; 9: 386-93.
20. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: A naturalistic study. J Clin Psychiatry 2000; 61: 804-8.
21. Perugi G, Micheli C, Akiskal HS et al. Polarity of the first episode, clinical characteristics, and course of manic depressive illness: A systematic retrospective investigation of 320 bipolar I patients. Compr Psychiatry 2000; 41: 13-18.
22. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry 1995; 152: 1130-8.
23. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004; 161: 163-5.
24. Leverich GS, Altshuler LL, Frye MA et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006; 163: 232-9.
25. Post RM, Leverich GS, Nolen WA et al. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: Data from the Stanley Foundation Bipolar Networ. Bipolar Disord 2003; 5: 396-406.
26. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 1999; 156: 1264-6.
27. Baethge C, Gruschka P, Smolka MN et al. Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder. J Psychiatry Neurosci 2003; 28: 355-61.
28. Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: Relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord 2003; 5: 169-79.
29. Clarke M, Whitty P, Browne S et al. Suicidality in first episode psychosis. Schizophr Res 2006; 86: 221-5.
30. Kessing LV, Andersen PK. Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders. Curr Psychiatry Rep 2005; 7: 413-20.
31. Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 1998; 28: 1027-38.
32. Kessing LV, Andersen PK. The effect of episodes on recurrence in affective disorder: A case register study. J Affect Disord 1999; 53: 225-31.
33. Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatr Scand 2004; 109: 339-44.
34. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-70.
35. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: A systematic review of cross-sectional evidence. Bipolar Disord 2006; 8: 103-16.
36. Bora E, Vahip S, Akdeniz F et al. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disord 2007; 9: 468-77.
37. Torrent C, Martinez-Aran A, Daban C et al. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006; 189: 254-9.
38. Clark L, Iverson SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-9.
39. van Gorp WG, Altshuler LL, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998; 55: 41-6.
40. Egeland JA, Hostetter AM, Pauls DL, Sussex JN. Prodromal symptoms before onset of manic-depressive disorder suggested by first hospital admission histories. J Am Acad Child Adolesc Psychiatry 2000; 39: 1245-52.
41. Shaw JA, Egeland JA, Endicott J, Allen CR, Hostetter AM. A 10-year prospective study of prodromal patterns for bipolar disorder among Amish youth. J Am Acad Child Adolesc Psychiatry 2005; 44: 1104-11.
42. Correll CU, Penzer JB, Frederickson AM et al. Differentiation in the preonset phases of schizophrenia and mood disorders: Evidence in support of a bipolar mania prodrome. Schizophr Bull 2007; 33: 703-14.
43. Thompson KN, Conus PO, Ward JL et al. The initial prodrome to bipolar affective disorder: Prospective case studies. J Affect Dis 2003; 77: 79-85.
44. Yung A, McGorry P. The initial prodrome in psychosis: Descriptive and qualitative aspects. Aust NZ J Psychiatry 1996; 30: 587-99.
45. Hantouche EG, Akiskal HS, Lancrenon S, Chatenet-Duchene L. Mood stabilizer augmentation in apparently 'unipolar' MDD: Predictors of response in the naturalistic French national EPIDEP study. J Affect Disord 2005; 84: 243-9.
46. Chang K, Steiner H, Dienes K, Adleman N, Ketter T. Bipolar offspring: A window into bipolar disorder evolution. Biol Psychiatry 2003; 53: 945-51.
47. Lapalme M, Hodgins S, LaRoche C. Children of parents with bipolar disorder: A metaanalysis of risk for mental disorders. Can J Psychiatry 1997; 42: 623-31.
48. Singh MK, DelBello MP, Stanford KE et al. Psychopathology in children of bipolar parents. J Affect Dis 2007; 102: 131-6.
49. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
50. Hillegers MH, Reichart CG, Wals M, Verhulst FC, Ormel J, Nolen WA. Five-year prospective outcome of psychopathology in the adolescent offspring of bipolar parents. Bipolar Disord 2005; 7: 344-50.
51. Conus PO, Berk M, McGorry P. Pharmacological treatment in the early phase of bipolar disorders: What stage are we at? Aust NZ J Psychiatry 2006; 40: 199-207.
52. Conus PO, McGorry P. First-episode mania: A neglected priority for early intervention. Aust NZ J Psychiatry 2002; 36: 158-72.
53. Farrow TF, Whitford TJ, Williams LM, Gomes L, Harris AW. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 2005; 58: 713-23.
54. Hirayasu Y, Shenton ME, Salisbury DF et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999; 156: 1091-3.
55. Strakowski SM, DelBello MP, Zimmerman ME et al. Ventricular and periventricular structural volumes in first-versus multiple-episode bipolar disorder. Am J Psychiatry 2002; 159: 1841-7.
56. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry 2007; 164: 582-90.
57. Strakowski SM, Keck P, McElroy SL et al. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry 1998; 55: 49-55.
58. Tohen M, Hennen J, Zarate CA et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000; 157: 220-8.
59. Strakowski SM, Williams JR, Fleck DE, DelBello MP. Eight-month functional outcome from mania following a first psychiatric hospitalization. J Psychiatr Res 2000; 34: 193-200.
60. Nehra R, Chakrabarti S, Pradhan BK, Khehra N. Comparison of cognitive functions between first- and multi-episode bipolar affective disorders. J Affect Dis 2006; 93: 185-92.
61. Albus M, Hubmann W, Wahlheim C, Sobizack N, Franz U, Mohr F. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatr Scand 1996; 94: 87-93.
62. Gruber SA, Rosso IM, Yurgelen-Todd DA. Neuropsychological performance predicts clinical recovery in bipolar patients. J Affect Disord 2008; 105: 253-60.
63. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Dis 2006; 93: 105-15.
64. Holmes MK, Erickson K, Luckenbaugh D et al. A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Bipolar Disord 2008 (in press).
65. Ferrier IN, Chowdhury R, Thompson JM, Watson S, Young AH. Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: A preliminary report. Bipolar Disord 2004; 6: 319-22.
66. Pirkola T, Tuulio-Henriksson A, Glahn D et al. Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol Psychiatry 2005; 58: 930-6.
67. Klimes-Dougan B, Ronsaville D, Wiggs EA, Martinez PE. Neuropsychological functioning in adolescent children of mothers with a history of bipolar or major depressive disorders. Biol Psychiatry 2006; 60: 957-65.
68. Antila M, Tuulio-Henriksson A, Kieseppa T, Eerola M, Partonen T, Lonnqvist J. Cognitive functioning in patients with familial bipolar I disorder and their unaffected relatives. Psychol Med 2007; 37: 679-87.
69. Frangou S, Haldane M, Roddy D, Kumari V. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Biol Psychiatry 2005; 58: 838-9.
70. Clark L, Kempton MJ, Scarna A, Grasby PM, Goodwin GM. Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biol Psychiatry 2005; 57: 183-7.
71. Duffy A, Grof P, Kutcher S, Robertson C, Alda M. Measures of attention and hyperactivity symptoms in a high-risk sample of children of bipolar parents. J Affect Dis 2001; 67: 159-65.
72. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008; 38: 771-85.
73. Goldberg TE, Goldman RS, Burdick KE et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: Is it a practice effect? Arch Gen Psychiatry 2007; 64: 1115-22.
74. Drevets WC, Price JL, Simpson JRJ et al. Subguenal prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-7.
75. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-5.
76. Bowley MP, Drevets WC, Ongur D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-12.
77. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002; 12: 386-94.
78. Rajkowska G, Miguel-Hidalgo JJ, Wei J et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-98.
79. Stockmeier CA, Rajkowska G. Cellular abnormalities in depression: evidence from postmortem brain tissue. Dialogues Clin Neurosci 2004; 6: 185-97.
80. Tkachev D, Mimmack ML, Ryan MM et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798-805.
81. Webster MJ, O'Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005; 133: 453-61.
82. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord 2002; 4: 105-16.
83. Benes FM, Berretta S. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25: 1-27.
84. Cotter D, Landau S, Beasley C et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002; 51: 377-86.
85. Pantazopoulos H, Lange N, Baldessarini RJ, Berretta S. Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry 2007; 61: 640-52.
86. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 2001; 12: 3257-62.
87. Thompson PM, Egbufoama S, Vawter MP. SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 411-7.
88. Scarr E, Gray L, Keriakous D, Robinson PJ, Dean B. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disord 2006; 8: 133-43.
89. Eastwood SL, Harrison PJ. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 2001; 55: 569-78.
90. Eastwood SL, Harrison PJ. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: A study of complexin mRNAs. Mol Psychiatry 2000; 5: 425-32.
91. Rosoklija G, Toomayan G, Ellis SP et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000; 57: 349-56.
92. Gallelli KA, Wagner CM, Karchemskiy A et al. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disord 2006; 7: 589-97.
93. Atmaca M, Yildirim H, Ozdemir H, Ogur E, Tezcan E. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol Med 2007; 37: 121-9.
94. Blasi G, Bertolino A, Brudaglio F et al. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: A proton magnetic resonance spectroscopic imaging study. Psychiatry Res 2004; 131: 95-105.
95. Velakoulis D, Wood S, Wong MT et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: A magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006; 63: 139-49.
96. Noga JT, Vladar K, Torrey EF. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res 2001; 106: 25-34.
97. Berger G, Dell'Olio M, Amminger P et al. Neuroprotection in emerging psychotic disorders. Early Int Psychiatry 2007; 1: 114-27.
98. Adler CM, Levine AD, DelBello MP, Strakowski SM. Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 2005; 58: 151-7.
99. Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 2007; 61: 776-81.
100. Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999; 877: 614-37.
101. Mayberg HS, Brannan SK, Mahurin RK et al. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 1997; 8: 1057-61.
102. Rich BA, Vinton DT, Roberson-Nay R et al. Limbic hyperactivation during processing of neutral facial expressions in children with bipolar disorder. Proc Natl Acad Sci USA 2006; 103: 8900-5.
103. Rosso IM, Killgore WD, Cintron CM, Gruber SA, Tohen M, Yurgelen-Todd DA. Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter. Biol Psychiatry 2007; 61: 743-9.
104. Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 2003; 985: 420-44.
105. DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: A pilot study. Neuropsychopharmacology 1999; 21: 63-8.
106. Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL. Structural brain abnormalities in first-episode mania. Biol Psychiatry 1993; 33: 602-9.
107. Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post RM. T2 hyperintensities in bipolar disorder: Magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 1995; 152: 1139-44.
108. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disord 2001; 3: 106-50.
109. Dupont RM, Jernigan TL, Butters N et al. Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Clinical and neuropsychological significance. Arch Gen Psychiatry 1990; 47: 55-9.
110. Stoll AL, Renshaw PF, Yurgelen-Todd DA, Cohen BM. Neuroimaging in bipolar disorder: What have we learned? Biol Psychiatry 2000; 48: 505-17.
111. Swayze VW, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry 1990; 47: 1054-9.
112. Heiden A, Kettenbach J, Fischer P et al. White matter hyperintensities and chronicity of depression. J Psychiatr Res 2005; 39: 285-93.
113. Kalayam B, Alexopoulos GS. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 1999; 56: 713-8.
114. Taylor WD, Steffens DC, MacFall JR et al. White matter hyperitensity progression and late-life depression. Arch Gen Psychiatry 2003; 60: 1090-6.
115. Thomas AJ, O'Brien JT, Davis S et al. Ischemic basis for deep white matter hyperintensities in major depression: A neuropathological study. Arch Gen Psychiatry 2002; 59: 785-92.
116. Lyoo IK, Lee HK, Jung JH, Noam GG, Renshaw PF. White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr Psychiatry 2002; 43: 361-8.
117. Pillai JJ, Friedman L, Stuve TA et al. Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder. Psychiatry Res 2002; 114: 51-6.
118. Lenox RH, Gould TD, Manji HK. Endophenotypes in bipolar disorder. Am J Med Genet 2002; 114: 391-406.
119. Moore PB, Schepherd DJ, Eccleston D et al. Cerebral white matter lesions in bipolar affective disorder: Relationship to outcome. Br J Psychiatry 2001; 178: 172-6.
120. Ehrlich S, Breeze JL, Hesdorffer DC et al. White matter hyperintensities and their association with suicidality in depressed young adults. J Affect Dis 2005; 86: 281-7.
121. Pompili M, Ehrlich S, De Pisa E et al. White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur Arch Psychiatry Clin Neurosci 2007; 257: 494-9.
122. Adler CM, Adams J, DelBello MP et al. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: A diffusion tensor imaging study. Am J Psychiatry 2006; 163: 322-4.
123. Atmaca M, Ozdemir H, Yildirim H. Corpus callosum areas in first-episode patients with bipolar disorder. Psychol Med 2007; 37: 699-704.
124. Brambilla P, Nicoletti MA, Sassi RB et al. Magnetic resonance imaging study of corpus callosum abnormalities in patients with bipolar disorder. Biol Psychiatry 2003; 54: 1294-7.
125. Kieseppa T, van Erp TG, Haukka J et al. Reduced left hemispheric white matter volume in twins with bipolar I disorder. Biol Psychiatry 2003; 54: 896-905.
126. Nugent AC, Milham MP, Bain EE et al. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 2006; 30: 485-97.
127. Moorhead TW, McKirdy J, Sussman JE et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007; 62: 894-900.
128. Kugaya A, Sanacora G. Beyond monoamines: Glutamatergic function in mood disorders. CNS Spectr 2005; 10: 808-19.
129. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925-35.
130. McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999; 22: 105-22.
131. McEwen BS. The neurobiology of stress: From serendipity to clinical relevance. Brain Res 2000; 886: 172-89.
132. Zarate CA Jr, Singh J, Manji HK. Cellular plasticity cascades: Targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 2006; 59: 1006-20.